"We have received orphan drug designation for azer-cel from the U.S. Food and Drug Administration for the treatment of ALL and MCL, as well as Fast Track Designation for azer-cel for the treatment of B-ALL."
This is off the Precision BioSciences website. Azer-cel is an orphan drug with fast track approval. I wonder what will happen when adding CF-33
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-23
-
- There are more pages in this discussion • 484 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 5.7¢ | $1.583M | 26.53M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 3027963 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 878840 | 29 |
View Market Depth
| Last trade - 14.29pm 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |